Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$61.91 - $67.42 $82,649 - $90,005
-1,335 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $59 - $66
-1 Reduced 0.07%
1,335 $84,000
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $519 - $588
-9 Reduced 0.67%
1,336 $83,000
Q3 2020

Nov 09, 2020

SELL
$57.43 - $63.64 $2,871 - $3,182
-50 Reduced 3.58%
1,345 $81,000
Q2 2020

Aug 12, 2020

SELL
$54.82 - $64.09 $657 - $769
-12 Reduced 0.85%
1,395 $82,000
Q1 2020

May 12, 2020

BUY
$46.4 - $67.43 $1,763 - $2,562
38 Added 2.78%
1,407 $78,000
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $1,673 - $2,182
34 Added 2.55%
1,369 $88,000
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $598 - $709
14 Added 1.06%
1,335 $68,000
Q2 2019

Aug 08, 2019

SELL
$44.62 - $49.34 $64,788 - $71,641
-1,452 Reduced 52.36%
1,321 $60,000
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $79,050 - $94,257
-1,752 Reduced 38.72%
2,773 $132,000
Q4 2018

Feb 06, 2019

BUY
$48.76 - $63.23 $1,706 - $2,213
35 Added 0.78%
4,525 $235,000
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $3,421 - $3,859
62 Added 1.4%
4,490 $279,000
Q2 2018

Aug 09, 2018

BUY
$50.53 - $62.98 $200,048 - $249,337
3,959 Added 844.14%
4,428 $245,000
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $187,130 - $215,424
-3,123 Reduced 86.94%
469 $0
Q4 2017

Feb 13, 2018

SELL
$59.94 - $65.35 $505,294 - $550,900
-8,430 Reduced 70.12%
3,592 $220,000
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $663,975 - $766,282
12,022
12,022 $766,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sun Life Financial Inc Portfolio

Follow Sun Life Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sun Life Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sun Life Financial Inc with notifications on news.